At 40 Years Old, the Orange Book Gets a Fresh Look as FDA Seeks Comments on Patent Listability September 18, 2020
Even If the Federal Circuit Could Award Attorney Fees for IPR Appeals, § 285 Does Not Permit It to Award Fees Incurred During the IPR June 11, 2020
New Treatments for COVID-19: Recent International Activity Relating to IP and Some Tools the US Already Has in Place April 9, 2020
“Numerous Reasons” Support Finding Inequitable Conduct: Another Example of the Federal Circuit’s Current Approach to Inequitable Conduct April 2, 2020
Delaware Provides More Insight into the Scope of the Rights Derived by a Patent Term Extension February 21, 2020
